The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2020-21.
This overview is to assist regulated organisations to understand which gene editing and RNA interference techniques result in GMOs.
Tables of all current commercially released GM plants in Australia and their OECD unique identifiers.
Details of temporary licences issued to someone who has come into possession of a genetically modified organism (GMO) without realising or intending to.
The overall finding of the 2021 survey is that while there have not been massive shifts since 2019, and despite the impact of the COVID-19 pandemic experience, there is stronger support for genetic modification generally at 39% of high support in 2021, up from 33% in 2019.
Details of OGTR monitoring and compliance activities during the quarter ended 30 September 2021.
Clinical trial with a genetically modified human adenovirus COVID-19 vaccine
Limited and controlled release of canola and Indian mustard genetically modified for altered oil content and herbicide tolerance
DIR 155, DIR 139, DIR 138 and DIR 127 annual reports.